Skip to content
Screener

Enovis ENOV Common Stock

Common Stock at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
Stryker logo
StrykerSYK
$38M0.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$4.07M+3.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$3.2M0.0%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$65K+3.2%
ESAB logo
ESABESAB
600M0.0%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.53B-5.5%
Enterprise value$2.83B-4.9%
P/S0.7×-0.1×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemJuly 3, 2026December 31, 2025
Other liabilities368,630424,568
Total liabilities2,286,9612,342,835
Equity:
Common stock, $0.001 par value; 133,333,333 shares authorized; 57,665,074 and 57,194,781 shares issued and outstanding as of July 3, 2026 and December 31, 2025, respectively5857
Additional paid-in capital3,065,6673,048,414
Accumulated deficit(1,477,417)(1,467,463)
Accumulated other comprehensive loss(111,241)(91,363)
Total Enovis Corporation equity1,477,0671,489,645

Item 1. Financial Statements

FAQ

What is Enovis's common stock?
Enovis (ENOV) reported common stock of 133.3M in Q2 2026.
How has Enovis's common stock changed year-over-year?
Enovis's common stock decreased by 0.0% year-over-year, from 133.3M to 133.3M.
What is the long-term trend for Enovis's common stock?
Over 5 years (2020 to 2025), Enovis's common stock has grown at a 308.0% compound annual growth rate (CAGR), from 118K to 133.3M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Enovis's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude